608
Participants
Start Date
December 19, 2022
Primary Completion Date
February 3, 2025
Study Completion Date
January 30, 2026
Povorcitinib
Oral; Tablet
Placebo
Oral; Tablet
Investigative Site US324, Kew Gardens
Investigative Site GR300, Athens
Investigative Site FR304, Marseille
Investigative Site ES304, Santiago de Compostela
Investigative Site GR303, Athens
Investigative Site ES301, Granada
Investigative Site DE303, Hamburg
Investigative Site US325, Columbia
Investigative Site US333, Baltimore
Investigative Site US313, Norfolk
Investigative Site ES305, Madrid
Investigative Site FR303, Brest
Investigative Site DE300, Hanover
Investigative Site FR306, Toulouse
Investigative Site US316, Orlando
Investigative Site FR305, Bordeaux
Investigative Site US338, Margate
Investigative Site US306, Boca Raton
Investigative Site US320, Boca Raton
Investigative Site US328, Tampa
Investigative Site US336, Tampa
Investigative Site ES300, Pontevedra
Investigative Site DE306, Düsseldorf
Investigative Site US341, Bowling Green
Investigative Site FR301, Saint-Priest-en-Jarez
Investigative Site US339, Bexley
Investigative Site FR302, Nantes
Investigative Site US312, Cleveland
Investigative Site US330, Boardman
Investigative Site US314, Cincinnati
Investigative Site US337, Indianapolis
Investigative Site GR301, Thessaloniki
Investigative Site GR302, Thessaloniki
Investigative Site US319, Skokie
Investigative Site DE301, Frankfurt am Main
Investigative Site US327, Chicago
Investigative Site US302, St Louis
Investigative Site DE305, Darmstadt
Investigative Site US334, Metairie
Investigative Site FR307, Le Mans
Investigative Site US335, Arkansas City
Investigative Site US307, Fort Smith
Investigative Site FR300, Paris
Investigative Site US300, Plano
Investigative Site US340, Bellaire
Investigative Site US303, Phoenix
Investigative Site US331, Albuquerque
Investigative Site DE307, Memmingen
Investigative Site DE304, Langenau
Investigative Site US326, Los Angeles
Investigative Site US315, Laguna Niguel
Investigative Site US323, San Francisco
Investigative Site US301, Portland
Investigative Site US308, Spokane
Investigative Site US317, Hialeah
Investigative Site US321, North Miami Beach
Investigative Site US311, Marietta
Investigative Site US318, Beverly
Investigative Site US304, Boston
Investigative Site US310, Brighton
Investigative Site AT304, Graz
Investigative Site 00A, Innsbruck
Investigative Site AT306, Innsbruck
Investigative Site AT302, Linz
Investigative Site AT305, Vienna
Investigative Site AT301, Vienna
Investigative Site AT300, Vienna
Investigative Site BE300, Brussels
Investigative Site BE304, Brussels
Investigative Site BE301, Ghent
Investigative Site BE306, Ghent
Investigative Site BE305, Leuven
Investigative Site BE302, Liège
Investigative Site BE303, Namur
Investigative Site CA301, Winnipeg
Investigative Site CA304, Barrie
Investigative Site CA308, Hamilton
Investigative Site CA303, London
Investigative Site CA302, Peterborough
Investigative Site CA306, Laval
Investigative Site CA307, Montreal
Investigative Site CA309, Québec
Investigative Site CZ301, Ostrava - Poruba
Investigative Site CZ300, Prague
Investigative Site DE302, Dresden
Investigative Site JP304, Itabashi-ku
Investigative Site JP305, Kurume-shi
Investigative Site JP300, Kyoto
Investigative Site JP301, Nakagami-gun
Investigative Site JP303, Niigata
Investigative Site JP307, Nishinomiya-shi
Investigative Site JP308, Sapporo
Investigative Site JP302, Sendai
Investigative Site JP309, Shinjuku-ku
Investigative Site JP306, Tsukuba
Investigative Site NL302, Breda
Investigative Site NL303, Groningen
Investigative Site NL301, Rotterdam
Investigative Site PL304, Ostrowiec
Investigative Site PL303, Poznan
Investigative Site PL301, Wroclaw
Investigative Site PL302, Wroclaw
Investigative Site ES302, Badalona
Investigative Site ES303, Barcelona
Lead Sponsor
Incyte Corporation
INDUSTRY